FDB (First Databank) vs Medi-Span (Wolters Kluwer) (2026)
FDB (First Databank) is the Hearst Health company whose drug database sits inside much of the prescribing and pharmacy software in the United States. Record, pharmacy and payer software companies license its MedKnowledge content, and FDB says it reaches more than 3,500 non federal hospitals and 32,000 retail pharmacies. It now builds AI of its own as well. Script Agent turns the conversation in an exam room into prescriptions a clinician approves, and it went into commercial use with Tebra in August 2026. Medi-Span is the drug data product of Wolters Kluwer Health, the company behind UpToDate. Wolters Kluwer says it is used by 17 of the 20 top grossing pharmacy benefit managers and 7 of the 10 top grossing record vendors, for claims, formularies, dispensing and clinical screening. It also publishes its own drug classification, the Generic Product Identifier. Medi-Span ships no model of its own. Its AI move is a Model Context Protocol server, opened to select AI developers in February 2026, so other companies' agents can query its content. Both now offer agent servers, so the real difference is what sits on top of the content. FDB is turning its knowledge into products it ships itself, and it states that it acts as a HIPAA business associate for its customers. Medi-Span stays a content supplier, publishes a detailed account of how its editors build that content, and states no HIPAA position for the services that take patient data. A team that wants a finished prescribing agent grounded in drug knowledge has a product to evaluate at FDB. A team building its own agents, or running claims and formulary work, will find Medi-Span's editorial detail and payer reach easier to weigh.
- Script Agent turns exam room conversation into structured prescriptions, and a clinician modifies or approves each one before it is sent; its first commercial deployment runs inside Tebra's AI Note Assist for independent practices.
- MedProof MCP, generally available since 31 March 2026, lets other companies' AI agents query FDB drug knowledge in patient specific context.
- Its privacy notice states that FDB acts as a HIPAA business associate for its customers, with patient information governed by the customer agreements.
- FDB says its content reaches more than 3,500 non federal hospitals, more than 32,000 retail pharmacies and 16 of the top 24 health plans, and it names athenahealth, MEDITECH, NextGen Healthcare and Greenway Health among its customers.
- An approved prescription can travel on through FDB Vela, FDB's own ePrescribing network linking prescribers, pharmacies and payers.
- Its editorial process is published in detail, including a team of nearly 150 advanced degreed clinicians and weekly research on medication guides, REMS and drug shortages.
- Wolters Kluwer says it is used by 17 of the 20 top grossing pharmacy benefit managers and 7 of the 10 top grossing record vendors, and it publishes its own drug classification, the Generic Product Identifier.
- Its clinical screening takes age, weight, body surface area, renal function, conditions, pregnancy and lactation status and pharmacogenomic factors as inputs, with dose ranges for adult, pediatric and neonatal patients.
- Customers choose flat files, locally hosted APIs or web services, and the first two keep patient data inside their own systems.
- Since July 2026, eligible Epic customers, including rural hospitals and federally qualified health centers, can take it inside Epic alongside UpToDate Lexidrug and patient education content.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. FDB (First Databank) and Medi-Span (Wolters Kluwer) are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | FDB (First Databank) | Medi-Span (Wolters Kluwer) |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Headquarters | South San Francisco, California, United States | Waltham, Massachusetts, United States |
| Website | fdbhealth.com | wolterskluwer.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
FDB (First Databank)
-
Product / capability
FDB commercially deployed FDB Script Agent, an AI prescribing tool that converts ambient patient encounter dialogue directly into structured prescriptions.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached.
FDB, the brand of First Databank, Inc., is a Hearst Health company that licenses drug knowledge to the software companies, hospitals, pharmacies and health plans that build medication decisions into their systems. Its MedKnowledge database supplies the interaction, dosing and contraindication content behind many prescribing and pharmacy alerts, and FDB says it reaches more than 3,500 non federal hospitals and 32,000 retail pharmacies. It now adds AI on top. MedProof MCP serves that content to outside AI agents, and Script Agent drafts prescriptions from exam room conversation for a clinician to approve, in commercial use with Tebra since August 2026. FDB states that it acts as a HIPAA business associate, but it publishes no security attestation, no price, and no evaluation of its AI products beyond a May 2026 poster on pharmacy alerts.
Source: AI Health Index, November 2026
Medi-Span is Wolters Kluwer Health's drug data product, licensed mainly by pharmacy benefit managers, health plans, record vendors and pharmacies for claims processing, formularies, dispensing and clinical screening. It delivers drug information, screening content, pricing data and its own Generic Product Identifier classification as flat files, locally hosted APIs or web services. Wolters Kluwer publishes a detailed editorial process behind the content, and since February 2026 a Model Context Protocol server lets select AI developers ground their agents in it. The main caveat is that Medi-Span states no HIPAA position and no security attestation for the web services and agent server that receive patient attributes, and it publishes no price.
Source: AI Health Index, November 2026
Questions buyers ask
How does First Databank compare to Medi-Span?
Both license drug knowledge that other software companies build into prescribing, pharmacy and claims systems. First Databank (FDB) has its content in much of American hospital and pharmacy software and is building AI products of its own, including Script Agent for drafting prescriptions.
Medi-Span, from Wolters Kluwer Health, reports use by 17 of the 20 top grossing pharmacy benefit managers, publishes a detailed editorial process, and gives AI agents access to its content without shipping a model of its own. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 3, 2026. No vendor pays for placement.
How much do FDB and Medi-Span cost?
Neither FDB nor Medi-Span publishes a price, a unit of charge or an implementation fee. Both license content by module or content set, and many organizations pay for it inside the license of the record, pharmacy or claims system they already run. Neither says whether an existing content license covers access through its agent server. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 3, 2026. No vendor pays for placement.
Do FDB and Medi-Span act as HIPAA business associates?
FDB's privacy notice states that it acts as a HIPAA business associate for its customers, with patient information governed by the customer agreement, although the agreement itself is not published. Medi-Span states no HIPAA position for its web services or its agent server, which take patient attributes such as age, weight and renal function. Customers who load Medi-Span data or host its APIs in their own systems send Wolters Kluwer no patient information. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 3, 2026. No vendor pays for placement.
Can AI agents use FDB and Medi-Span drug content?
Yes, through a Model Context Protocol server from each. FDB's MedProof MCP has been generally available since 31 March 2026, and FDB also sells Script Agent, its own prescribing agent. Medi-Span's server opened to select AI developers in February 2026 under the Medi-Span Expert AI name, and Wolters Kluwer ships no model of its own on top of it. Neither publishes an evaluation of agents grounded on its content. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 3, 2026. No vendor pays for placement.
What evidence do FDB and Medi-Span publish?
FDB's main figure comes from a May 2026 AMIA poster by its own pharmacists. Patient specific screening at a large national community pharmacy, which FDB does not name, cut alerts from 241.5 to fewer than 50 per 250 prescriptions, with no sample size or study period given. Medi-Span reports that 98 percent of customers are satisfied with its data and 99 percent are likely to renew, without method or sample.
Neither publishes a peer reviewed study of its content's accuracy or of patient outcomes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 3, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Medication Safety & Prescribing page.
Neither FDB nor Medi-Span publishes a price, a SOC 2 report, an ISO 27001 certificate or a trust center for these products. Wolters Kluwer's certifications cover products in other divisions, not Medi-Span. Neither holds or claims an FDA clearance, which is usual for drug content licensed into other companies' software. FDB publishes no regulatory position for Script Agent, which drafts prescriptions from a recorded conversation, and Medi-Span publishes none for agent use of its content.
FDB names no hosting provider or subprocessor for MedProof MCP or Script Agent, and Medi-Span names none for its web services or agent server. Ask FDB for its business associate agreement, the Script Agent data flow and how long query and audio data are kept. Ask Medi-Span whether its web services and agent server are meant to receive protected health information, and whether a business associate agreement covers them. Ask both whether an existing content license extends to agent access.